Breast cancer care across CION centres in Hyderabad · ArogyaSri, CGHS & cashless insurance accepted · Call 1800 202 8726

Survivorship and recovery

When does recurrence risk actually fall?

For most breast cancers, the chance of recurrence is highest in the first few years and then falls. The pattern differs by type: triple-negative and HER2-positive cancers mostly return early, while hormone-positive cancers carry a low risk for many years. This page explains the timing, the factors involved and what helps.

Call 1800 202 8726

Speak to an oncologist

Book a consultation

Talk to a breast cancer specialist at a CION centre near you.

Free call back. Your details stay private.

NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating

The short answer

When does the risk of breast cancer coming back actually fall?

For most breast cancers, the chance of recurrence is highest in the first two to three years after diagnosis and then falls steadily. The pattern depends strongly on the type of cancer. Triple-negative and HER2-positive cancers, when they return, tend to do so early, mostly within the first few years. If you reach five years without recurrence, the chance of these types coming back later becomes low. Hormone- positive breast cancers behave differently. Their risk also peaks in the early years, but it falls more slowly and continues at a lower, steady level for many years, even beyond ten or fifteen years. This is why hormone therapy is often taken for five years and sometimes extended to seven or ten years for women at higher risk. Other factors influence the overall level of risk: the size of the original cancer, how many lymph nodes were involved, the grade, how well the cancer responded to treatment given before surgery, and whether all recommended treatment was completed. Every year that passes without recurrence is genuinely good news, because it means your remaining risk is lower than it was. Your oncologist can use your reports to give a more personal sense of how your risk is likely to change over time and what that means for your follow-up.

The first few years carry the most risk

For most types, recurrence is most likely early and becomes less likely with each passing year.

Type changes the pattern

Hormone-negative cancers mostly return early; hormone-positive cancers can return late.

Each clear year is good news

Time without recurrence lowers your remaining risk.

This page gives general information only. Your oncologist can discuss your own risk.

By cancer type

How the timing of risk differs

These are general patterns seen in large groups of women.

Triple-negative

Risk is concentrated in the first three years. After five years without recurrence, late return is uncommon.

HER2-positive

Risk is mostly early as well. Targeted treatment has greatly lowered recurrence for this type.

Hormone-positive HER2 cancers can share both patterns.

Hormone-positive

Risk falls after the early years but continues at a low, steady level for a long time.

DCIS

Recurrence is usually in the same breast and may be pre-invasive or invasive.

Lowered by

  • Clear surgical margins
  • Radiation after lumpectomy
  • Hormone therapy in some women

Not sure whether this applies to you?

Ask an oncologist

Over time

How recurrence risk generally changes

Time since diagnosis General pattern
First to third year Highest risk period for most breast cancers
Fourth and fifth years Risk falling; hormone-negative cancers become less likely to return
Five to ten years Low for hormone-negative types; ongoing low risk for hormone-positive types
Beyond ten years Late recurrence is possible mainly with hormone-positive cancer
Any time A new cancer in either breast can occur, which is why mammograms continue

Words you may hear

The vocabulary, in plain language

Recurrence risk
The chance that breast cancer will come back after treatment.
Early recurrence
Cancer returning within the first five years after diagnosis.
Late recurrence
Cancer returning more than five years after diagnosis.
Disease-free survival
The length of time after treatment that a person lives without cancer returning.
Extended hormone therapy
Continuing hormone tablets beyond five years to lower late recurrence.
Dormant cells
Cancer cells that may survive treatment and stay inactive for years.

Leave a number, we will call you

One field. No form to fill in, and no charge for the call.

Being straight with you

Honest realities about recurrence risk

Numbers and patterns can help, but they have limits worth understanding.

There is no single all-clear date

Risk falls gradually rather than disappearing on a particular anniversary.

Group patterns do not predict individuals

Some women with high-risk features never have recurrence, and some with low-risk features do.

Treatments keep improving

Figures come from women treated years ago and may overestimate risk today.

What this page cannot tell you

It cannot calculate your risk. Your oncologist can estimate it using your reports.

Talk to our team

Have a question about your situation?

Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.

Call 1800 202 8726 Helpline open 24/7

Request a call back

Share your number and a specialist's team will call you.

Free call back. Your details stay private.

What shapes your level

Factors that raise or lower your overall risk

Timing is one part of the picture. These features affect how high your risk is to begin with.

Lymph node involvement

More nodes with cancer generally means a higher risk.

Tumour size and grade

Larger and faster-growing cancers carry more risk.

Response to treatment before surgery

Cancer that disappears completely with chemotherapy usually has a lower risk afterwards.

Genomic test results

Tests on hormone-positive tumours can help estimate the risk of recurrence.

Completing treatment

Finishing radiation, chemotherapy and hormone therapy lowers risk.

What you can do

Steps that help keep your risk as low as possible

You cannot control every factor, but these choices make a real difference over time.

Stay on hormone therapy

Side effects can be managed; stopping early raises the chance of recurrence.

Keep active

Regular walking or exercise is linked with lower recurrence risk.

Aim for a healthy weight

Weight gain after treatment is linked with higher risk for some cancers.

Limit alcohol and avoid smoking

Both are linked with worse outcomes and other health problems.

Living with it

Coping with uncertainty as the years pass

Knowing that risk falls slowly rather than stopping on a set date can feel unsettling. Many survivors find that worry fades gradually as normal life fills the space that treatment once took up.

Mark milestones in your own way

Some women quietly note each clear year, while others prefer not to count at all. Either approach is fine, and neither changes your actual risk.

Expect worry around check-ups

Anxiety often rises in the days before a mammogram or clinic visit. Planning something pleasant afterwards can help you get through that stretch.

Ask for support if fear takes over

If fear of recurrence stops you sleeping, working or enjoying family life, tell your care team. Counselling and survivor groups help many people feel calmer and more in control.

Commonly believed

What people assume about recurrence timing

After five years, breast cancer can never return.

Hormone-positive cancers can occasionally return later, though the risk is low.

Risk stays the same every year.

For most women, risk is highest early and falls over time.

Triple-negative cancer is always more dangerous long term.

After several clear years, its risk of return becomes low.

Nothing you do affects recurrence.

Completing treatment and healthy habits help lower the risk.

Questions we are asked

Common questions about when recurrence risk falls

Is five years without recurrence the all-clear?

Five years is a useful milestone, especially for triple-negative and HER2-positive cancers, where late recurrence becomes uncommon. For hormone-positive cancers, some risk continues beyond five years, so follow-up and sometimes extended hormone therapy continue. It is a very encouraging point, not a promise that risk has gone completely.

Why can hormone-positive cancer return so late?

Some cancer cells may survive treatment and stay inactive for years before starting to grow again. Hormone-positive cells seem particularly able to do this. Hormone therapy helps keep them in check, which is why longer treatment is sometimes advised.

Should I extend my hormone therapy?

Extended therapy is usually discussed for women with higher-risk hormone-positive cancer, such as those with lymph node involvement, who are coping well with the tablets. The small benefit is balanced against side effects such as bone thinning. Your oncologist will help you decide.

Does my follow-up become less frequent as risk falls?

Yes. Visits are most frequent in the early years when risk is highest, and become yearly later on. Yearly mammograms continue long term. Report new, lasting symptoms at any time, whatever your schedule says.

Can a genomic test tell me my late recurrence risk?

Some genomic tests on hormone-positive tumours estimate the risk of distant recurrence and whether chemotherapy is likely to help. A few have been studied for late recurrence. They give useful estimates, but no test can predict exactly what will happen to one person.

Is my risk higher because I am young?

Younger women tend to have more active cancer types and more years ahead, which can raise overall risk. Treatment is often adjusted to account for this, for example with ovarian suppression. Age is one factor among many your oncologist considers.

Does anxiety about recurrence ever go away?

For many women it fades gradually as years pass and life fills up again, though it may flare before check-ups or on anniversaries. If worry is constant or affects sleep and daily life, counselling and support groups can help a great deal.

If cancer returns late, is it treatable?

Yes. Late recurrences of hormone-positive cancer often grow slowly and respond well to hormone-based treatments. The goal depends on where it returns, and many women live well for long periods with treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation
Real Stories. Real Voices.

15,000+ patients chose CION. Hear from them directly.

These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.

4.8★800+ Google reviews
50+video testimonials
15,000+patients treated

Successful Chemotherapy Done by Dr. C Raghavendra Reddy

Watch video →

Surgery, Chemo & Radiation Done by Dr. Imaduddin, Dr. Vinay, Dr. Owais, Dr. Kirti

Watch video →

Successful Radical Thymectomy Done by Dr. Mohammed Imaduddin & Dr. Vinay Mamidala

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Radiation Done by Dr. Owais Mohammed & Dr. Kirti Ranjan Mohanty

Watch video →

Successful Breast Cancer Surgery Done by Dr. Imaduddin Mohammed & Dr. Vinay Mamidala

Watch video →

Successful Chemotherapy Done by Dr. Bharati Devi Gorantla

Watch video →

Successful Chemo & Surgery Done by Dr. Owais Mohammed & Dr. Imaduddin Mohammed

Watch video →

Successful Chemotherapy Done by Dr. Gundu Naresh

Watch video →

Successful Bone Marrow Transplantation - Neuroblastoma

Watch video →

Successful Surgery & Chemo - Carcinoma of Caecum

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Surgery by Dr. Mohammed Imaduddin

Watch video →

Successful Bone Marrow Transplantation

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Buccal Mucosa Surgery

Watch video →

Successful Complex Surgery Mandibulectomy Reconstruction

Watch video →

Where to find us

Our centres in and around Hyderabad

Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.

CION Ameerpet

Beside Blue Fox Hotel, Satyam Theatre Road

Begumpet SR Nagar Punjagutta
CION Kukatpally

Opposite Big Bazaar, Mumbai Highway

KPHB JNTU Bharat Nagar
CION L.B. Nagar

Anu Arcade, next to L.B. Nagar Metro station

Vanasthalipuram Nagole Hayathnagar
CION Tolichowki

Inside Premier Hospital, Khader Bagh Road

Mehdipatnam Attapur Rethibowli
CION Masab Tank

Mahavir Hospital, AC Guards, Lakdikapul

Lakdikapul Khairatabad Basheer Bagh
CION Banjara Hills

Road No. 12

Jubilee Hills Madhapur Film Nagar
CION Kompally

Suchitra Circle, NH-44

Suchitra Circle Alwal Dundigal
CION Balanagar

Balanagar Main Road

Balanagar Fatehnagar Moosapet
CION Siddipet

Lohith Sai Hospital, Shivaji Nagar

Gajwel Husnabad Dubbaka
CION Sangareddy

X Roads, Pothreddipalle

Narayankhed Zaheerabad Patancheru

Talk to our team

Speak to a breast cancer specialist

Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.

Call 1800 202 8726 Helpline open 24/7

Request a call back

Share your number and a specialist's team will call you.

Free call back. Your details stay private.

Sources

  1. American Cancer Society — Recurrent breast cancer
  2. Cancer.Net — Breast cancer: statistics
  3. Breast Cancer Now — Fear of breast cancer coming back

This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.

Call 1800 202 8726Book a consultation
Explore more

Breast Cancer Topics

Browse our complete guide to breast cancer — types, symptoms, tests and treatments. Tap any topic to read more.

HER2-Targeted Therapy

Cost of a full year of HER2 therapy in India De-escalated HER2 treatment for small tumours What happens if your heart function drops during treatment? Ejection fraction monitoring on HER2 therapy HER2-low breast cancer HER2-positive and hormone-positive together The full HER2 treatment pathway How does pertuzumab work, and who is it for? How does trastuzumab emtansine work, and who is it for? How long will you be on pertuzumab? Is adding pertuzumab worth the extra cost? Missed a dose of pertuzumab? What to do Missed a dose of trastuzumab emtansine? What to do Neratinib as extended adjuvant HER2 therapy Pertuzumab, fertility, menopause and sexual health How much does pertuzumab actually help? The numbers explained Pertuzumab cost in India Diarrhoea and rash on pertuzumab Heart function monitoring on dual HER2 blockade Pertuzumab infusion day Medicines, foods and supplements to avoid on pertuzumab Tests and monitoring while you are on pertuzumab Pertuzumab myths Pertuzumab (Perjeta) for breast cancer Pertuzumab side effects Pertuzumab T-DM1 infusion day Liver enzyme rises and nerve changes on T-DM1 Low platelets and bleeding risk on T-DM1 T-DM1 myths T-DM1 vs continuing trastuzumab after residual disease Trastuzumab emtansine (T-DM1) after residual disease Trastuzumab biosimilars in India Trastuzumab emtansine, fertility, menopause and sexual health How much does trastuzumab emtansine actually help? The numbers explained Trastuzumab emtansine cost in India Medicines, foods and supplements to avoid on trastuzumab emtansine Trastuzumab emtansine side effects Trastuzumab emtansine (Kadcyla) for breast cancer Lapatinib and tucatinib Why exactly twelve months of trastuzumab?

Hormone Therapy Medicines

Anastrozole, fertility, menopause and sexual health How much does anastrozole actually help? The numbers explained Anastrozole cost in India Medicines, foods and supplements to avoid on anastrozole Cholesterol, bone density and long-term effects of anastrozole Tests and monitoring while you are on anastrozole Anastrozole myths Anastrozole side effects Anastrozole vs tamoxifen Anastrozole (Arimidex) for breast cancer Exemestane, fertility, menopause and sexual health How much does exemestane actually help? The numbers explained Exemestane cost in India Medicines, foods and supplements to avoid on exemestane Joint pain and fatigue on exemestane Tests and monitoring while you are on exemestane Exemestane myths Exemestane side effects Why exemestane is taken after food and its steroidal effects Exemestane (Aromasin) for breast cancer Fulvestrant, fertility, menopause and sexual health How much does fulvestrant actually help? The numbers explained Fulvestrant cost in India Injection site pain and reactions on fulvestrant The fulvestrant injection Medicines, foods and supplements to avoid on fulvestrant Tests and monitoring while you are on fulvestrant Fulvestrant myths Fulvestrant side effects Fulvestrant vs aromatase inhibitors in advanced disease Fulvestrant (Faslodex) for breast cancer How much does goserelin actually help? The numbers explained Bone loss and mood changes on ovarian suppression Goserelin cost in India The goserelin implant Medicines, foods and supplements to avoid on goserelin Sudden menopause symptoms from ovarian suppression Tests and monitoring while you are on goserelin Goserelin myths Goserelin side effects Goserelin injections vs surgical ovary removal Goserelin (Zoladex) for breast cancer Hot flushes, joint pain and fatigue on fulvestrant How does anastrozole work, and who is it for? How does exemestane work, and who is it for? How does fulvestrant work, and who is it for? How does goserelin work, and who is it for? How does letrozole work, and who is it for? Postmenopausal hormone-receptor-positive breast cancer How long will you be on anastrozole? How long will you be on exemestane? How long will you be on fulvestrant? How long will you be on goserelin? How long will you be on letrozole? Taking anastrozole Taking exemestane Taking letrozole Letrozole, fertility, menopause and sexual health How much does letrozole actually help? The numbers explained Bone thinning on letrozole Letrozole cost in India Medicines, foods and supplements to avoid on letrozole Joint pain and morning stiffness on letrozole Tests and monitoring while you are on letrozole Letrozole myths Letrozole side effects Letrozole vs anastrozole vs exemestane Letrozole (Femara) for breast cancer Missed a dose of anastrozole? What to do Missed a dose of exemestane? What to do Missed a dose of fulvestrant? What to do Missed a dose of goserelin? What to do Missed a dose of letrozole? What to do Exemestane after letrozole or anastrozole Will your periods and fertility return after stopping goserelin?

Targeted & Newer Medicines

Abemaciclib, fertility, menopause and sexual health How much does abemaciclib actually help? The numbers explained Abemaciclib cost in India Diarrhoea on abemaciclib Two years of abemaciclib after surgery Medicines, foods and supplements to avoid on abemaciclib Tests and monitoring while you are on abemaciclib Abemaciclib myths Abemaciclib side effects Abemaciclib vs other CDK4/6 inhibitors Abemaciclib (Verzenio) for breast cancer CDK4/6 inhibitors in early breast cancer after surgery Adjuvant olaparib after surgery for BRCA carriers Alpelisib, fertility, menopause and sexual health How much does alpelisib actually help? The numbers explained Alpelisib cost in India High blood sugar on alpelisib Medicines, foods and supplements to avoid on alpelisib Tests and monitoring while you are on alpelisib Alpelisib myths Alpelisib (Piqray) for breast cancer Rash and mouth sores on alpelisib Alpelisib side effects Alpelisib vs everolimus after endocrine therapy fails Alpelisib for PIK3CA-mutated breast cancer CDK4/6 inhibitors in breast cancer Everolimus in hormone-resistant breast cancer How does abemaciclib work, and who is it for? How does ribociclib work, and who is it for? How does sacituzumab govitecan work, and who is it for? How long will you be on alpelisib? How long will you be on ribociclib? How long will you be on sacituzumab govitecan? Taking abemaciclib Taking alpelisib Taking ribociclib Liquid biopsy in metastatic breast cancer Missed a dose of abemaciclib? What to do Missed a dose of alpelisib? What to do Missed a dose of ribociclib? What to do Missed a dose of sacituzumab govitecan? What to do Newer drugs Elacestrant and oral SERDs for ESR1-mutant disease PARP inhibitors for BRCA-mutated breast cancer Do you need a PIK3CA test before alpelisib? Ribociclib, fertility, menopause and sexual health How much does ribociclib actually help? The numbers explained Ribociclib cost in India ECG monitoring and QT prolongation on ribociclib Medicines, foods and supplements to avoid on ribociclib Low white cell counts on ribociclib Tests and monitoring while you are on ribociclib Ribociclib myths Ribociclib side effects Ribociclib (Kisqali) for breast cancer Sacituzumab govitecan, fertility, menopause and sexual health How much does sacituzumab govitecan actually help? The numbers explained Sacituzumab govitecan cost and availability in India Diarrhoea on sacituzumab govitecan and how it is managed Medicines, foods and supplements to avoid on sacituzumab govitecan Tests and monitoring while you are on sacituzumab govitecan Sacituzumab govitecan myths Low counts, fever risk and hair loss on sacituzumab govitecan Sacituzumab govitecan infusion days Sacituzumab govitecan side effects Sacituzumab govitecan for triple-negative breast cancer Sacituzumab govitecan vs standard chemotherapy in triple negative breast cancer How newer drugs are sequenced with older ones

Metastatic Breast Cancer

What comes after a CDK4/6 inhibitor stops working? Ascites and abdominal swelling in advanced breast cancer Is my back pain bone metastasis or something else? Bone marrow involvement in advanced breast cancer Bone metastases in breast cancer Brain metastases in breast cancer Tumour markers CA 15-3 and CEA in metastatic breast cancer Chest wall and local recurrence after mastectomy Clinical trials in metastatic breast cancer Cost of long-term metastatic breast cancer treatment in India Explaining metastatic breast cancer to family and friends First-line treatment for hormone-positive metastatic breast cancer Confusion, thirst and drowsiness Lines of treatment in metastatic breast cancer Liver metastases in breast cancer Living well with metastatic breast cancer for years Lung metastases and pleural effusion in breast cancer Malignant pleural effusion Metastatic breast cancer and pink-ribbon culture Prognosis in metastatic breast cancer Treatment sequence in metastatic HER2-positive breast cancer Treatment options in metastatic triple negative breast cancer Oligometastatic breast cancer Why receptors are re-tested on a metastatic biopsy Scan intervals and monitoring in metastatic disease Understanding scan reports in metastatic breast cancer Skin metastases and nodules on the chest Surgery and radiation in metastatic breast cancer Treatment holidays and breaks in metastatic breast cancer When do doctors switch treatment in metastatic disease? Where breast cancer spreads and what each site feels like Working and earning with metastatic breast cancer
Call now Book free consultation